Voriconazole (X-GEN Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Voriconazole drug offered from X-GEN Pharmaceuticals, Inc.. This Azole Antifungal [EPC],Azoles [Chemical/Ingredient],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | X-GEN Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | Voriconazole |
| SUBSTANCE NAME: | VORICONAZOLE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Azole Antifungal [EPC],Azoles [Chemical/Ingredient],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2017-03-09 |
| END MARKETING DATE: | 0000-00-00 |
Voriconazole HUMAN PRESCRIPTION DRUG Details:
| Item Description | Voriconazole from X-GEN Pharmaceuticals, Inc. |
| LABELER NAME: | X-GEN Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/mL) |
| START MARKETING DATE: | 2017-03-09 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 39822-1077_6b6a6819-7d9e-4001-936b-ebe76b921eeb |
| PRODUCT NDC: | 39822-1077 |
| APPLICATION NUMBER: | NDA208562 |
Other VORICONAZOLE Pharmaceutical Manufacturers / Labelers:
